90 research outputs found
Encarar a luz: retratos holográficos 3D
A Holografia, em termos de desenvolvimento futuro, e apesar dos trabalhos já realizados, tem ainda muitos caminhos para percorrer, quer seja a nível do melhoramento de materiais de registo, quer da resolução de problemas técnicos, quer a nível expressivo e criativo.
Há vários tipos de hologramas, mas os usados com fins artísticos são os de imagem, registados na maior parte com lasers contínuos de He-Ne ou de Argon. Porém, o registo de hologramas de pessoas vivas ou de objectos instáveis só são possíveis usando lasers pulsados, o que obriga a duas fases de trabalho. A primeira, onde se obtém o holograma primário, de transmissão e visível apenas com luz laser e a segunda, para a obtenção do holograma secundário, de reflexão, visível com luz branca. Os hologramas assim obtidos são tridimensionais. Para a realização destes Retratos Holográficos 3D, usou-se um laser de Rubi para o registo dos hologramas primários, usando-se posteriormente um laser de He-Ne para os hologramas secundários.
Este projecto de trabalho, na área da Holografia Artística, é a continuação do trabalho de investigação anteriormente realizado, quer no âmbito da tese de doutoramento, quer posteriormente. No que diz respeito à Holografia Artística, mesmo seguindo caminhos já percorridos, os hologramas resultantes serão sempre diferentes, devido à concepção individualizada e original que cada artista-hológrafo imprime ao seu trabalho, quer seja na conceptualização, quer seja na expressão. Como acontece com qualquer das outras tecnologias artísticas, cada artista usa o medium de maneira diferente e com diferentes resultados.
O retrato tem sido, ao longo dos tempos, um dos temas mais utilizados na arte. Assim sendo, não é de admirar que também na holografia seja um tema considerado importante. O rosto constitui uma zona corporal privilegiada de comunicação e expressão. O rosto manifesta a emoção interior através de olhares, sorrisos, traços, gestos, movimento constante. Embora, por vezes, o que é expresso possa ser interpretado de maneira equívoca, ambígua, como acontece no retrato da Mona Lisa, de Leonardo, há o interesse suscitado pela singularidade do que foi captado, que torna a percepção difícil.
Sendo a Holografia a tecnologia de registo conhecida até ao momento, que representa o objecto mais semelhante ao original, poderemos cair numa representação mimética da realidade. Há a necessidade, portanto, de evidenciar uma relação de semelhança entre a imagem e o modelo, que seja subjectiva, embora partindo de uma realidade objectiva. Isto é, transcender o objecto.In terms of future development and despite all the works already carried out, there are still plenty of ways for Holography to cross, not only as far as expression and creativity are concerned but also improving recording materials and resolving technical problems.
There are various types of holograms, but image holograms are the ones used for artistic purposes, mostly with He-Ne or Argon continuous lasers. However, recording holograms of living persons or unstable objects is only possible by using pulsed lasers, which requires two work steps. The first allows the master hologram to be obtained – a transmission master hologram, visible only in the laser light. The second provides the secondary hologram – a reflection hologram, visible in the white light. Holograms obtained through this method are 3D holograms. In these 3D Holographic Portraits a Ruby laser was used for the record of the master holograms and then a He-Ne laser for the secondary holograms.
This work project in the area of Artistic Holography is the continuation of the research carried out before, both in the scope of my PhD thesis and afterwards. As far as Artistic Holography is concerned, and even following the already existing tracks, the holograms obtained will always be different owing to the individualised and original conception that the holograph-artist prints in his work be it in the conceptualisation or in the expression. Like in any other artistic technology, each artist uses the medium in a different way, obtaining different results.
Portrait has always been one of the themes mostly used in art. So, no wonder that it is also seen as an important theme in holography. A face is a privileged communication and expression body zone. A face shows the internal emotion through the look, smile, traces, gestures, the constant motion. Though sometimes what is expressed may be misinterpreted or understood in an ambiguous way, like in Leonardo’s portrait of Mona Lisa, there is an interest aroused by the singularity of what was captured , which makes the perception all the more difficult.
Being Holography the recording technology known up to the moment that best represents the original object due to its great similarity, we may be trapped in a mimetic representation of reality. Therefore, it is necessary to clearly show a relationship of similarity between the image and the model, which ought to be subjective, though starting from an objective reality. That is, transcending the object
Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study
Background
Alpha-1 antitrypsin deficiency (AATD) is the most common hereditary disorder in adults, but is under-recognized. In Spain, the number of patients diagnosed with AATD is much lower than expected according to epidemiologic studies. The objectives of this study were to assess the frequency and determinants of testing serum α1-antitrypsin (AAT) levels in COPD patients, and to describe factors associated with testing.
Methods
EPOCONSUL is a cross-sectional clinical audit, recruiting consecutive COPD cases over one year. The study evaluated serum AAT level determination in COPD patients and associations between individual, disease-related, and hospital characteristics.
Results
A total of 4,405 clinical records for COPD patients from 57 Spanish hospitals were evaluated. Only 995 (22.5%) patients had serum AAT tested on some occasion. A number of patient characteristics (being male [OR 0.5, p < 0.001], ≤55 years old [OR 2.38, p<0.001], BMI≤21 kg/m2 [OR 1.71, p<0.001], FEV1(%)<50% [OR 1.35, p<0.001], chronic bronchitis [OR 0.79, p < 0.001], Charlson index ≥ 3 [OR 0.66, p < 0.001], or history or symptoms of asthma [OR 1.32, p<0.001]), and management at a specialized COPD outpatient clinic [OR 2.73,p<0.001] were identified as factors independently associated with ever testing COPD patients for AATD. Overall, 114 COPD patients (11.5% of those tested) had AATD. Of them, 26 (22.8%) patients had severe deficiency. Patients with AATD were younger, with a low pack-year index, and were more likely to have emphysema (p<0.05).
Conclusion
Testing of AAT blood levels in COPD patients treated at outpatient respiratory clinics in Spain is infrequent. However, when tested, AATD (based on the serum AAT levels ≤100 mg/dL) is detected in one in five COPD patients. Efforts to optimize AATD case detection in COPD are needed.SEPA
A comparative analysis of mass spectrometry studies
Funding Information: Funding: R.M. is supported by Fundação para a Ciência e a Tecnologia (CEEC position, 2019–2025 investigator). This article is a result of the projects (iNOVA4Health—UIDB/04462/2020), supported by Lisboa Portugal Regional Operational Programme (Lisboa2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). This work is also funded by FEDER funds through the COMPETE 2020 Programme and National Funds through FCT—Portuguese Foundation for Science and Technology under the projects number PTDC/BTM-TEC/30087/2017 and PTDC/BTM-TEC/30088/2017. Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.Molecular diagnostics based on discovery research holds the promise of improving screening methods for prostate cancer (PCa). Furthermore, the congregated information prompts the question whether the urinary extracellular vesicles (uEV) proteome has been thoroughly ex-plored, especially at the proteome level. In fact, most extracellular vesicles (EV) based biomarker studies have mainly targeted plasma or serum. Therefore, in this study, we aim to inquire about possible strategies for urinary biomarker discovery particularly focused on the proteome of urine EVs. Proteomics data deposited in the PRIDE archive were reanalyzed to target identifications of potential PCa markers. Network analysis of the markers proposed by different prostate cancer studies revealed moderate overlap. The recent throughput improvements in mass spectrometry together with the network analysis performed in this study, suggest that a larger standardized cohort may provide potential biomarkers that are able to fully characterize the heterogeneity of PCa. According to our analysis PCa studies based on urinary EV proteome presents higher protein coverage compared to plasma, plasma EV, and voided urine proteome. This together with a direct interaction of the prostate gland and urethra makes uEVs an attractive option for protein biomarker studies. In addition, urinary proteome based PCa studies must also evaluate samples from bladder and renal cancers to assess specificity for PCa.publishersversionpublishe
Clinical management of COPD in a real-world setting. A Big Data analysis
9 p.Objective: The aim of this study was to evaluate the quality of diagnosis and treatment of COPD using Big Data methodology on the Savana Manager 2.1 clinical platform. Materials and methods: A total of 59,369 patients with a diagnosis of COPD were included from a population of 1,219,749 adults over 40 years of age. Results: In total, 78% were men. Spirometry data were available for only 26,453 (43.5%) subjects. Disease severity was classified in 18,172 patients: 4396 mild, 7100 moderate, and 6676 severe, although only 27%, 34%, and 28%, respectively, presented obstructive spirometry. The clinical management of COPD is mainly the responsibility of the primary care and pulmonology departments, while internal medicine and, to a lesser extent, geriatrics also participate. Drug treatment was based on bronchodilators and inhaled corticosteroids (ICS). A marked decline in the use of long-acting beta-2 agonists (LABA) in monotherapy and a slight reduction in ICS/LABA combinations, associated with a long-acting anticholinergic (LAMA) in 74% of cases, were observed. All-cause in-hospital mortality among the overall population was 5.6% compared to 1% of the general population older than 40 years. In total, 35% were admitted to hospital, with an average stay of 6.6 days and an in-hospital mortality rate in this group of 10.74%. Discussion: This study identifies the main features of an unselected COPD population and the main errors made in the management of the disease
Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter study
The study was designed and coordinated by the Respiratory Effectiveness Group (REG; www.effectivenessevaluation.org; Cambridge, UK) and delivered by Optimum Patient Care (OPC; www.optimumpatientcare.org). The following investigators participated in the study: Spain: Marc Miravitlles, Cristina Esquinas, Miriam Barrecheguren, Alexa Nuñez, Hospital Universitari Vall d’Hebron, Barcelona. Bernardino Alcazar, Hospital de Alta Resolución de Loja. Juan Luis García-Rivero, Karina Hueso, Hospital Comarcal de Laredo, Cantabria. Miguel Roman-Rodríguez, Primary Health-care Center Son Pisà. IB-Salut. Palma de Mallorca. Poland: Pawel Sliwinsk Sliwinski, Katarzyna Iwan, Jacek Kolakowski, Institute of Tuberculosis and Lung Diseases, Warsaw. Korea: Chin Kook Rhee, Esther Ahn, St Mary’s Hospital. Seoul. Singapore: Jessica Tan, Therese Lapperre, Karen Tan Li Leng, Nicole Chia, Ong Thun How, Syifa Binte Shamsuddin, Sherine Lim Shu Gim, Yap Chwee Bee, Soh Rui Ya, Singapore General Hospital. Augustine Tee, Jun Jie Yan, Samuel Hong, William Tan, Jessica Tan, Changi General Hospital. UK: Victoria Carter, Latife Hardaker, Andrew McLaughlin, Optimum Patient Care, Cambridge. Malta: Caroline Gouder, Mater Dei Hospital. Ireland: Richard W Costello, Royal College of Surgeons. Dublin. The study was funded by an unrestricted grant from Novartis AG.Peer reviewedPublisher PD
Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD
BACKGROUND: The concept of clinical control in COPD has been developed to help in treatment decisions, but it requires validation in prospective studies. METHOD: This international, multicenter, prospective study aimed to validate the concept of control in COPD [control = stability (no exacerbations or impairment in CAT scores) + low impact (low level of symptoms)]. Data from the screening visit was used to: investigate the level of control, compare characteristics of patients according to the control status, and perform a sensitivity analysis of the levels of control using either clinical criteria or questionnaires (COPD Assessment Test -CAT- or Clinical COPD Questionnaire -CCQ-). RESULTS: A total of 314 patients were analysed, mean age was 68.5 years and mean FEV1 was 52.6% of predicted. According to the prespecified criteria 21% of patients were classified as controlled, all of them with mild/moderate COPD (Body mass index, Obstruction, Dyspnea and Exacerbations, -BODEx-index <5). A high level of dyspnea, a high CAT score or an exacerbation in the previous 3 months were found, using univariate analysis, to be the main reasons for patients not being classified as controlled. Multivariate analysis showed that female sex, chronic bronchitis and having exacerbations in the previous year were associated with uncontrolled COPD. Changing the severity cut off of BODEx from 5 to 3 did not change significantly the percentage of patients fulfilling the criteria of control. CONCLUSIONS: The proposed criteria of control were only fulfilled by 21% of patients. The suggested cut offs and their predictive value for poor outcomes need to be refined in prospective studies
Changes in control status of COPD over time and their consequences : A prospective international, study
ACKNOWLEDGMENTS The study was designed and coordinated by the Respiratory Effectiveness Group (REG; www.effectivenessevaluation.org; Cambridge, UK) and delivered by Optimum Patient Care (OPC; www.optimumpatientcare.org). Funding: The study was funded by an unrestricted grant from Novartis AG.Peer reviewedPostprin
Predictive value of control of COPD for risk of exacerbations : An international, prospective study
Acknowledgements Collaborators/REG Investigators: Spain: Marc Miravitlles, Cristina Esquinas, Miriam Barrecheguren, Alexa Nuñez, Hospital Universitari Vall d'Hebron, Barcelona. Bernardino Alcazar, Hospital de Alta Resolución de Loja. Juan Luis García‐Rivero, Karina Hueso, Hospital Comarcal de Laredo, Cantabria. Miguel Roman‐Rodríguez, Primary Health‐Care Center Son Pisà, IB‐Salut, Palma de Mallorca. Poland: Pawel Sliwinsk, Katarzyna Iwan, Jacek Kolakowski, Institute of Tuberculosis and Lung Diseases, Warsaw. Korea: Chin Kook Rhee, Esther Ahn, St Mary's Hospital, Seoul. Singapore: Jessica Tan, Therese Laperre, Karen Tan Li Leng, Nicole Chia, Ong Thun How, Syifa Binte Shamsuddin, Sherine Lim Shu Gim, Yap Chwee Bee, Soh Rui Ya, Singapore General Hospital. Augustine Tee, Jun Jie Yan, Samuel Hong, William Tan, Changi General Hospital. UK: Victoria Carter, Latife Hardaker, Andrew McLaughlin, Optimum Patient Care, Cambridge. Malta: Caroline Gouder, Mater Dei Hospital. Ireland: Richard W Costello, Royal College of Surgeons, Dublin. The study was funded by an unrestricted grant from Novartis AG. The study was designed and coordinated by the Respiratory Effectiveness Group (REG; www.effectivenessevaluation.org; Cambridge, UK) and delivered by Optimum Patient Care (OPC; www.optimumpatientcare.org).Peer reviewedPostprin
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Introduction:
A recent genome-wide association study (GWAS) comprising a French cohort of systemic sclerosis (SSc) reported several non-HLA single-nucleotide polymorphisms (SNPs) showing a nominal association in the discovery phase. We aimed to identify previously overlooked susceptibility variants by using a follow-up strategy.<p></p>
Methods:
Sixty-six non-HLA SNPs showing a P value <10-4 in the discovery phase of the French SSc GWAS were analyzed in the first step of this study, performing a meta-analysis that combined data from the two published SSc GWASs. A total of 2,921 SSc patients and 6,963 healthy controls were included in this first phase. Two SNPs, PPARG rs310746 and CHRNA9 rs6832151, were selected for genotyping in the replication cohort (1,068 SSc patients and 6,762 healthy controls) based on the results of the first step. Genotyping was performed by using TaqMan SNP genotyping assays.
Results:
We observed nominal associations for both PPARG rs310746 (PMH = 1.90 × 10-6, OR, 1.28) and CHRNA9 rs6832151 (PMH = 4.30 × 10-6, OR, 1.17) genetic variants with SSc in the first step of our study. In the replication phase, we observed a trend of association for PPARG rs310746 (P value = 0.066; OR, 1.17). The combined overall Mantel-Haenszel meta-analysis of all the cohorts included in the present study revealed that PPARG rs310746 remained associated with SSc with a nominal non-genome-wide significant P value (PMH = 5.00 × 10-7; OR, 1.25). No evidence of association was observed for CHRNA9 rs6832151 either in the replication phase or in the overall pooled analysis.<p></p>
Conclusion:
Our results suggest a role of PPARG gene in the development of SSc
Ayotzinapa y la crisis del estado neoliberal mexicano
¿Qué pasó en Ayotzinapa? Es la pregunta que surgió el 26 de septiembre de 2014, que no encuentra una respuesta satisfactoria pese a la intervención de actores de distintas instancias, niveles y nacionalidades, y al esbozo de múltiples hipótesis sobre los enfrentamientos registrados en Iguala, Guerrero, que derivaron en la muerte de varias personas y la desaparición de 43 estudiantes de la Normal Rural “Isidro Burgos”, en una tragedia que evidenció la crisis que atraviesa el estado mexicano y que afecta a todo el país.
A partir de lo acontecido en Ayotzinapa y con base en la teoría general de los campos de Pierre Bourdieu y su propuesta de análisis teórico metodológico sobre el estado, en esta obra se realiza un análisis de la práctica sistemática y generalizada de las desapariciones forzadas en México, con el fin de ofrecer otra manera de comprender el entretejido político–económico–social que hace posible este grave fenómeno, que desgarra tanto a familias como a la comunidad.
La herida abierta por Ayotzinapa sangra y el objetivo último de este libro es contribuir a evitar que se cierre en tanto no se responda la interrogante de qué pasó ahí y que crímenes de lesa humanidad como este sigan aconteciendo en México.ITESO, A.C
- …